We don’t just treat cancer. We treat patients who have cancer. By creating a relationship that helps guide our patients through their journey, we provide personalized cancer care. We understand that there are a lot of emotions, questions, and concerns that come with treatment. We also know that every patient and every diagnosis is different. That’s why we’re dedicated to providing support every step of the way.
Designed for Patients
Our state-of-the-art facility was completed in 2011 and is designed with our patients’ comfort, convenience, and healing in mind. It’s a space that connects nature and nurture. During treatment, our patients have the option of privacy or connecting with their fellow patients. They can relax in heated massage chairs with a soothing view of dancing fountains and manicured gardens. Floor-to-ceiling windows showcase outside gardens and fountains that enhance healing.
As part of our patient-focused care, we offer same-day appointments, and every patient receives care when it’s needed. All aspects of treatment are located here — from the lab to the treatment areas — just steps away from each other. The FREE valet parking helps limit the amount of walking patients have to do here.
Fighting for a Cure
We are a family of medical professionals who treat our patients like family. Together we fight cancer, and in the end, we’re there to celebrate when The Bell of Hope rings.
Cancers We Treat
- Breast cancers
- Male and female reproductive system cancers – cervical, endometrial, ovarian, prostate, testicular, uterine, and vaginal
- Gastrointestinal cancers – tumors of the GI tract, colon, duodenal, esophageal, gall bladder, liver, pancreatic, and stomach
- Head and neck cancers
- Hodgkin’s and non-Hodgkin’s lymphomas
- Lung cancers
- Multiple myeloma
- Neurological cancers
- Skin cancers
- Urinary tract cancers – bladder, kidney, and ureteral
Specialties: Cancer Care / Chemotherapy / Breast Health /
Board Certifications: Internal Medicine, Medical Oncology, Hospice and Palliative Medicine
HealthConnection Episodes: Lung Cancer
With more than 22 years as an oncologist, Dr. Hyman is an expert in treating cancer. But he doesn’t just treat cancer, he cares for the person with cancer. Dr. Hyman takes the time to talk with patients about their condition and treatment, because, to him, the patient comes first.(903) 877-7831
Specialties: Cancer Care / Family Medicine /
It takes a special kind of person to support and care for cancer patients. Because of her special certification for nursing cancer patients, Paulia Jacobs is just the person for the job. She has more than 17 years of experience as a registered nurse, spending 10 of those years treating people with cancer. In addition, Ms. Jacobs has the expert training of a nurse practitioner.(903) 877-7343
Specialties: Cancer Care / Family Medicine /
HealthConnection Episodes: Palliative Care
After graduating from the UT Health Northeast Family Medicine Residency program, Dr. Amy Newton completed her fellowship in palliative care at MD Anderson Cancer Center. As a supportive care specialist, she and her team concentrate on a multidisciplinary approach to treating people that have serious illness. She focuses on relieving the symptoms of serious illness with the goal of improving quality of life for her patients. She and her team also have training in end of life care and discussions.(903) 877-7831
Specialties: Cancer Care / Surgery / Breast Health /
Board Certifications: Surgery
Dr. Sauter is a nationally known cancer surgeon and researcher. For over 20 years he has dedicated his practice to the prevention and early detection of breast cancer. His research and clinical trials contribute to improving the health of women now and for future generations.(903) 877-7831
Specialties: Cancer Care / Radiation / Breast Health /
Board Certifications: Radiation Oncology
HealthConnection Episodes: Cancer
To Dr. Smith, patients aren’t numbers; they are individuals with lives separate from their cancer treatments. That’s why he carefully explains complicated medical procedures and answers questions about their radiation therapy. Providing patients with treatment options and letting them choose what’s best for them creates a collaborative and personalized care plan.
TrueBeam™ and TrueBeam™ STx from Varian
Designed with patient comfort in mind, both the TrueBeam™ and TrueBeam™ STx deliver powerful, fast, and accurate treatment to cancer tumors. With these technological capabilities, Varian named our facility a Center of Excellence. This recognition draws doctors and administrators from all over the world to UT Health to see how we are utilizing the TrueBeam™ technology.
Not every cancer center invests in a machine like Acuity™, which allows our experts to prepare and verify treatment plans for efficient delivery. This dedicated machine frees up valuable treatment time on the TrueBeam™, giving patients more access to cancer-fighting technology. Acuity produces high-quality images to check treatment progress and is one of the latest and best technologies in cancer care.
ARIA® is an information and image management tool that documents patients’ journey through treatment.
Eclipse™ is a system that simplifies modern radiation therapy planning for all kinds of treatment. This technology helps us tailor treatment plans for each patient.
EQUICARE CS™ is a web-based solution that helps us operate our Future of Hope Survivorship Program so patients can connect and share stories after treatment is over.
We have a special room equipped with video conferencing capabilities that enables us to communicate face-to-face with cancer experts around the world.
We understand that there are many questions and concerns about treating cancer. As the destination of hope for cancer care, we want you to have the resources you need. For helpful information, services, and amenities, get the guide to UT Health.
Your First Visit
When arriving at the UT Health Northeast Cancer Treatment and Prevention Center, take advantage of the complimentary valet parking and then head inside to sign in at the registration desk. During your first visit, you will meet with a medical oncologist who will evaluate your condition and perform a physical exam. Once your medical records are reviewed, your physician will discuss your treatment options with you.
This consultation can take up to an hour-and-a-half. We encourage you to bring a friend or family member for extra support. The other important things to bring include:
- A list of all medications and supplements you currently take
- Medical records and films — like x-rays and CT scans — that pertain to your cancer diagnosis
- Insurance card
- Insurance company authorization or referral forms, if applicable
Paying for Treatment
Worrying about unknown financial details should not be an added burden. The financial counselor in the Cancer Center can help you get the most out of your insurance and benefits. Our goals are to regularly communicate with you about treatment costs and work with you and your insurance company to make sure all questions are answered.
For patients with limited resources, we will work with you to identify any financial aid you may be qualified for.
Cancer Preventative Clinical Trials
In the following studies, physicians and scientists analyze samples of body fluids and/or tissue to determine if they can identify nontoxic strategies to prevent cancer.
The purpose of this study is to compare proteins (biomarkers) in breast milk and colostrum with nipple aspirate fluid from women of different ages and breast cancer risk who are breastfeeding. This research is being done to learn more about biomarkers of pregnancy associated breast cancer.
The purpose of this study is to determine if Vitamin D and celecoxib (Celebrex), act together to decrease breast cancer risk by their effect on prostaglandins, which are biological indicators (biomarkers) of breast cancer risk. The medications to be used in this study are not approved by the Food and Drug Administration (FDA) for the prevention of breast cancer; therefore, this study is investigational in nature.
There is strong evidence that obesity is associated with chronic inflammation in the breast, which increases breast cancer risk. The purpose of this study is to determine if inflammatory markers are differentially expressed over time based on body mass index and menopausal status in the breast and systemically.
The purpose of this study is to collect specimens (any one or combination of the following: breast fluid, breast cells, blood breast tissue, and/or lung tissue) to analyze current and future biomarkers.
There is evidence from animal studies that resveratrol, a natural compound found in red grape skin, red wine, peanuts, mulberries, and certain other plants such as Japanese knotweed, decreases inflammation. Obesity is known to cause a state of chronic inflammation, which increases breast cancer risk. The purpose of this study is to determine if resveratrol decreases biological indicators of inflammation, and if this decrease is associated with body mass index.
Cancer Treatment Clinical Trials
These studies enroll participants diagnosed with cancer with the goal of identifying new methods to treat the disease. The trials may ask the participant to undergo surgery, take medication, and/or receive radiation therapy as part of the study. Additionally, the collection of blood or other body fluids, as well as imaging of the body to determine treatment response may be involved.
A study comparing two different combinations of chemotherapy in the treatment of metastatic breast cancer in patients who have received two or more prior regimens of chemotherapy.
This is a Phase III, multicenter, randomized trial looking at the value of local surgical therapy for the intact primary tumor in metastatic breast cancer patients. Patients will be followed for 5 years.
This study is being done to determine the efficacy and safety of treatment with the study drug in postmenopausal women with HR+, HER-negative advanced breast cancer who have received no prior therapy for advanced disease.
This study is testing the safety and tolerability of the study drug and to determine the maximum tolerated dose (MTD) in patient with non-small cell lung cancer (NSCLC), metastatic breast cancer (MBC), colorectal cancer (CRC), castrate-resistant prostate cancer (CRPC), melanoma, and ovarian cancer.
This study is being done to evaluate the good and bad effects of Entinostat in the treatment of hormone receptor positive advanced breast cancer.
For more information, please contact:
Benji Hawkins, CCRC